Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-03

Clinical Trial Update: Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block [NA]

View source ↗

Summary

A clinical trial evaluating two doses of dexmedetomidine as an adjuvant to bupivacaine for a TAP block to treat postoperative pain; the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Post Operative Pain | NA | Status: NOT_YET_RECRUITING